CompletedNot Applicable

Impact of Skin Type on Wonud Healing and Scarring Following Facial Skin Surgery

China173 participantsStarted 2025-06-15

Plain-language summary

The goal of this observational study is to learn how an individual's skin type influences the wound healing process and scar formation in Chinese patients undergoing facial dermatologic surgery. The main questions it aims to answer are: How does skin type affect the quality of wound healing after facial surgery? How does skin type affect the formation of hypertrophic scars after facial surgery? Researchers will compare groups of patients with different skin types (classified by the Baumann Skin Type) to see if there are significant differences in their healing outcomes and scar characteristics. Participants in this study will: Receive standard facial dermatologic surgery as part of their clinical care. Have their skin type assessed preoperatively. Undergo scheduled postoperative follow-up assessments at 7 and 90 days to evaluate wound healing and scar development using standardized scales.

Who can participate

Age range

14 Years – 60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Aged between 14 and 60 years. * Clinically and postoperatively pathologically diagnosed with a facial benign tumor (e.g., melanocytic nevus, sebaceous cyst, seborrheic keratosis, etc.) and having undergone standard surgical treatment. * Voluntary participation in this study with written informed consent obtained. * Commitment to comply with all study protocols and to complete all follow-up visits and data collection procedures. Exclusion Criteria: * Clinically or postoperatively diagnosed with a facial malignant tumor. * Wounds requiring staged excision or planned for secondary intention healing. * Surgical site located on or adjacent to the mucosal surface. * Known history of allergy to any medications or dressings to be used during or after surgery. * Presence of systemic diseases that significantly impair wound healing (e.g., poorly controlled diabetes, immunodeficiency disorders, active infections). * Current use of medications affecting wound healing or scar formation (e.g., long-term systemic corticosteroids, immunosuppressants). * Pregnancy or lactation. * Refusal to provide written informed consent, or anticipated inability to comply with study follow-up and data collection. * Concurrent participation in another interventional clinical trial. * Any other condition deemed by the investigator as likely to interfere with study results or increase participant risk.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Patient and Observer Scar Assessment Scale version 2.0 (POSAS 2.0)

Timeframe: 3-month follow-up

modified Stony Brook Scar Evaluation Scale (mSBSES)

Timeframe: 3-month follow-up

Trial details

NCT IDNCT07384299

SponsorUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-01-15

View on ClinicalTrials.gov More Nevus trials